Pharmacy consulting in Germany →
Connect medicines procurement, stock, cash flow and pharmacy QMS with a practical action plan. Advice is scoped to the German pharmacy market, your workflows and the team's responsibilities.
Pharmacy · Pharmaceutical wholesale · GDP · Availability · Germany
ZYPADHERA 210 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(483mg+3ml): German shortage and pharmacy procurement
ZYPADHERA 210 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(483mg+3ml): overview of shortage reports captured for Germany (BfArM). PZN 07373230. Reported packs and periods are shown separately.
Data retrieved:
Related support for your pharmacy ↓
| Official German product name / PZN | Start | Expected end | Latest report | Reported reason | Scope of the report |
|---|---|---|---|---|---|
| ZYPADHERA 210 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(483mg+3ml) PZN: 07373230 Ingredients as reported: Olanzapinembonat-Monohydrat Dosage form as reported: Pulver,Lösungsmittel ATC: N05AH03 | 19.09.2026 | 02.12.2026 | 18.09.2026 | Production issue | Shortage reported by source BfArM |
ZYPADHERA 210 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(483mg+3ml): review product identity and procurement
The reported German PZN identifiers and periods concern the named product. Reconcile them with product master data, free and reserved stock, open orders and confirmed supplier responses. An expected end date does not confirm renewed deliveries. The status of other strengths or dosage forms cannot be inferred from this record.
Questions for pharmacy operations
- Match ZYPADHERA 210 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(483mg+3ml) with the affected packs
- Record outstanding orders and confirmed quantities separately
- Check ingredient, strength and dosage form in the product data
Turn a report into a practical action plan
Pharma consulting for Germany and Europe →
Pharmaceutical consulting for manufacturers, wholesalers and logistics teams: align medicines procurement, product data, quality responsibilities and distribution, with a defined project scope and implementation steps.
Stock and medicines availability analysis →
Reconcile German PZN identifiers, available and reserved stock, open orders and confirmed supplier responses before making procurement decisions.
Using a shortage report
Does a shortage report mean my pharmacy cannot obtain the product?
No. It is information about the named product and period. Actual supply to your pharmacy also depends on the exact German product identifier, supplier responses and available stock. Check those separately.
Source and reporting date
A selected reporting snapshot, not real-time supplier availability. BfArM and PEI publish information reported by pharmaceutical companies. An expected end date is not a confirmed delivery commitment. Check the current BfArM record and the supplier's response.
Medicine recalls, batch recalls and batch checks are based on publicly available AMK notices. Check the original AMK notice for affected batches and required actions.
This selection reflects the documented retrieval and is not a complete list of shortages. Reports may change. The BfArM database generally has no additional delivery-status information; enquiries should go to the pharmaceutical company concerned.
- BfArM: published shortage reports
- PEI: Vaccines
- AMK: Recalls and batch notices
Data retrieved: 2026-10-24